Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Influenza Diagnostics market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Influenza Diagnostics market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Influenza Diagnostics market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Influenza Diagnostics products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Influenza Diagnostics products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Influenza Diagnostics market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Influenza Diagnostics development has been the leading industry trend of Influenza Diagnostics market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Influenza Diagnostics Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
RIDT,RT-PCR,Cell Culture, Other |
| By Application Outlook |
Hospitals,POCT,Other (Laboratory Diagnosis, etc.) |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
BD Medical,Abbott (Include Alere),F.Hoffmann-La Roche,Siemens Healthcare,Analytik Jena,Quidel,Thermo Fisher Scientific,Meridian Bioscience,BioMerieux,SA Scientific,Enigma Diagnostics,Focus Diagnostics,Sekisui Diagnostics,Response Biomedical |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- BD Medical
- Abbott (Include Alere)
- F.Hoffmann-La Roche
- Siemens Healthcare
- Analytik Jena
- Quidel
- Thermo Fisher Scientific
- Meridian Bioscience
- BioMerieux
- SA Scientific
- Enigma Diagnostics
- Focus Diagnostics
- Sekisui Diagnostics
- Response Biomedical
Influenza Diagnostics Market, By Type
- RIDT
- RT-PCR
- Cell Culture
- Other
Influenza Diagnostics Market, By Application
- Hospitals
- POCT
- Other (Laboratory Diagnosis
- etc.)
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Influenza Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Influenza Diagnostics Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 RIDT Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 RT-PCR Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Cell Culture Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Influenza Diagnostics Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Influenza Diagnostics Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Influenza Diagnostics Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Influenza Diagnostics Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Influenza Diagnostics Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Influenza Diagnostics Market Assessment by Type
8.1 Asia Pacific Influenza Diagnostics Market Assessment by Application (Consumption and Market Share)
8.2 North America Influenza Diagnostics Market Assessment by Application (Consumption and Market Share)
8.3 Europe Influenza Diagnostics Market Assessment by Application (Consumption and Market Share)
8.4 South America Influenza Diagnostics Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Influenza Diagnostics Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 BD Medical
9.1.1 BD Medical Profiles
9.1.2 BD Medical Product Portfolio
9.1.3 BD Medical Influenza Diagnostics Business Performance
9.1.4 BD Medical Influenza Diagnostics Business Development and Market Status
9.2 Abbott (Include Alere)
9.2.1 Abbott (Include Alere) Profiles
9.2.2 Abbott (Include Alere) Product Portfolio
9.2.3 Abbott (Include Alere) Influenza Diagnostics Business Performance
9.2.4 Abbott (Include Alere) Influenza Diagnostics Business Development and Market Status
9.3 F.Hoffmann-La Roche
9.3.1 F.Hoffmann-La Roche Profiles
9.3.2 F.Hoffmann-La Roche Product Portfolio
9.3.3 F.Hoffmann-La Roche Influenza Diagnostics Business Performance
9.3.4 F.Hoffmann-La Roche Influenza Diagnostics Business Development and Market Status
9.4 Siemens Healthcare
9.4.1 Siemens Healthcare Profiles
9.4.2 Siemens Healthcare Product Portfolio
9.4.3 Siemens Healthcare Influenza Diagnostics Business Performance
9.4.4 Siemens Healthcare Influenza Diagnostics Business Development and Market Status
9.5 Analytik Jena
9.5.1 Analytik Jena Profiles
9.5.2 Analytik Jena Product Portfolio
9.5.3 Analytik Jena Influenza Diagnostics Business Performance
9.5.4 Analytik Jena Influenza Diagnostics Business Development and Market Status
9.6 Quidel
9.6.1 Quidel Profiles
9.6.2 Quidel Product Portfolio
9.6.3 Quidel Influenza Diagnostics Business Performance
9.6.4 Quidel Influenza Diagnostics Business Development and Market Status
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Profiles
9.7.2 Thermo Fisher Scientific Product Portfolio
9.7.3 Thermo Fisher Scientific Influenza Diagnostics Business Performance
9.7.4 Thermo Fisher Scientific Influenza Diagnostics Business Development and Market Status
9.8 Meridian Bioscience
9.8.1 Meridian Bioscience Profiles
9.8.2 Meridian Bioscience Product Portfolio
9.8.3 Meridian Bioscience Influenza Diagnostics Business Performance
9.8.4 Meridian Bioscience Influenza Diagnostics Business Development and Market Status
9.9 BioMerieux
9.9.1 BioMerieux Profiles
9.9.2 BioMerieux Product Portfolio
9.9.3 BioMerieux Influenza Diagnostics Business Performance
9.9.4 BioMerieux Influenza Diagnostics Business Development and Market Status
9.10 SA Scientific
9.10.1 SA Scientific Profiles
9.10.2 SA Scientific Product Portfolio
9.10.3 SA Scientific Influenza Diagnostics Business Performance
9.10.4 SA Scientific Influenza Diagnostics Business Development and Market Status
9.11 Enigma Diagnostics
9.12 Focus Diagnostics
9.13 Sekisui Diagnostics
9.14 Response Biomedical
10 World Influenza Diagnostics Market Assessment by Players
10.1 Global Influenza Diagnostics Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Influenza Diagnostics Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Influenza Diagnostics Price (USD/Unit) of Players 2014-2020
10.4 Global Influenza Diagnostics Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Influenza Diagnostics Sales Assessment of Players 2014-2020
11.1.2 North America Influenza Diagnostics Revenue Assessment of Players 2014-2020
11.1.3 North America Influenza Diagnostics Price Assessment of Players 2014-2020
11.1.4 North America Influenza Diagnostics Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Influenza Diagnostics Sales Assessment of Players 2014-2020
11.2.2 Europe Influenza Diagnostics Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Influenza Diagnostics Price Assessment of Players 2014-2020
11.2.4 Europe Influenza Diagnostics Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Influenza Diagnostics Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Influenza Diagnostics Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Influenza Diagnostics Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Influenza Diagnostics Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Influenza Diagnostics Sales Assessment of Players 2014-2020
11.4.2 South America Influenza Diagnostics Revenue Assessment of Players 2014-2020
11.4.3 South America Influenza Diagnostics Price Assessment of Players 2014-2020
11.4.4 South America Influenza Diagnostics Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Influenza Diagnostics Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Influenza Diagnostics Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Influenza Diagnostics Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Influenza Diagnostics Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Influenza Diagnostics Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Influenza Diagnostics Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Influenza Diagnostics Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Influenza Diagnostics Sales by Countries/Regions 2014-2020
12.2.2 North America Influenza Diagnostics Revenue by Countries/Regions 2014-2020
12.2.3 North America Influenza Diagnostics Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Influenza Diagnostics Sales by Countries/Regions 2014-2020
12.3.2 Europe Influenza Diagnostics Revenue by Countries/Regions 2014-2020
12.3.3 Europe Influenza Diagnostics Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Influenza Diagnostics Sales by Countries/Regions 2014-2020
12.4.2 South America Influenza Diagnostics Revenue by Countries/Regions 2014-2020
12.4.3 South America Influenza Diagnostics Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Influenza Diagnostics Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Influenza Diagnostics Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Influenza Diagnostics Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Influenza Diagnostics Sales & Revenue Forecast 2021-2026
14.1 World Influenza Diagnostics Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Influenza DiagnosticsSales and Market Share by Regions
14.1.2 World Influenza DiagnosticsRevenue and Market Share by Regions
15 Asia Influenza Diagnostics Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 RIDT
15.1.2 RT-PCR
15.1.3 Cell Culture
15.2 Consumption Forecast by Application, 2021-2026
16 North America Influenza Diagnostics Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 RIDT
16.1.2 RT-PCR
16.1.3 Cell Culture
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Influenza Diagnostics Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 RIDT
17.1.2 RT-PCR
17.1.3 Cell Culture
17.2 Consumption Forecast by Application, 2021-2026
18 South America Influenza Diagnostics Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 RIDT
18.1.2 RT-PCR
18.1.3 Cell Culture
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Influenza Diagnostics Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 RIDT
19.1.2 RT-PCR
19.1.3 Cell Culture
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Influenza Diagnostics Price (USD/Unit) Trend 2021-2026
20.2 Global Influenza Diagnostics Gross Profit Trend 2021-2026
21 Conclusion
